Torasemid gehört zu den Top 10 der am häufigsten verordneten Wirkstoffe in Deutschland. Als Schleifendiuretikum entwässert es den Körper bei Herzschwache, Ödemen und Bluthochdruck – und hat dabei entscheidende Vorteile gegenüber dem älteren Furosemid.
Doch wie jedes Diuretikum greift Torasemid in den Elektrolythaushalt ein, kann Kalium und Magnesium senken und ist Teil der gefürchteten Triple-Whammy-Kombination mit Schmerzmitteln und Blutdrucksenkern. Dieser Ratgeber erklärt, worauf Sie achten müssen.
.gif)
Take torasemide in the morning! Never stop diuretics on your own initiative. Monitor electrolytes regularly.
Torasemide is a second-generation loop diuretic — and in heart failure management an increasingly preferred diuretic over the older furosemide. The main reason: a considerably more stable bioavailability (80–90% versus 10–90% with furosemide) and the option of once-daily dosing. It is approximately 2.5 times more potent than furosemide, which is important when converting between the two agents.
| Property | Details |
|---|---|
| Active substance | Torasemide (also spelled torsemide) |
| ATC code | C03CA04 |
| Drug class | Loop diuretic |
| Available forms | Tablets 2.5 / 5 / 10 / 20 / 50 / 100 / 200 mg |
| Half-life | 3–4 hours (duration of action: up to 12 hours) |
| Bioavailability | 80–90% (stable! Advantage vs. furosemide) |
| Metabolism | Hepatic (CYP2C8/9) — no accumulation in renal impairment |
| Timing | Once daily in the morning |
| Prescription only | Yes |
| Special feature | approx. 2.5× more potent than furosemide; less potassium loss |
Torasemide blocks the Na⁺/K⁺/2Cl⁻ cotransporter in the ascending limb of the loop of Henle in the kidney. This transporter normally reabsorbs sodium, potassium, and chloride from the tubular fluid back into the blood. When torasemide blocks it, these electrolytes remain in the urine and are excreted — together with water. The result: the body loses fluid.
In heart failure, this is the decisive mechanism: the weakened heart no longer pumps efficiently; fluid accumulates in the legs, lungs, and abdomen. Torasemide reduces the circulating blood volume — cardiac preload and afterload fall, oedema recedes, and breathlessness improves.
Torasemide has a pharmacological additional effect that furosemide does not: it mildly inhibits the action of aldosterone. Aldosterone is the hormone that normally causes the kidneys to excrete more potassium and retain more sodium. This mild aldosterone inhibition by torasemide explains why patients on torasemide lose less potassium compared to furosemide. This is clinically relevant — potassium depletion is one of the most dangerous effects of loop diuretics.
Torasemide dosing depends strongly on the indication. Particularly important: in hypertension there is a strict upper limit of 5 mg — higher doses provide no additional blood pressure benefit but increase side effects.
| Indication | Starting dose | Target / Max dose | Note |
|---|---|---|---|
| Hypertension | 2.5 mg once daily | 5 mg (maximum!) | Dose increase no sooner than after 2 months |
| Heart failure (oedema) | 5 mg once daily | 20 mg | Increase slowly based on weight and clinical status |
| Severe renal impairment | 50 mg once daily | 200 mg | Only under close medical supervision |
| Dialysis patients | Individual | 200 mg | Maintaining residual diuresis |
Furosemide has been the most widely used loop diuretic for decades — and has a well-known weakness: its widely variable bioavailability of 10–90%. This means the same oral dose can have very different effects from patient to patient, or in the same patient from day to day. Torasemide does not have this problem: 80–90% bioavailability, stable and reliable.
| Property | Torasemide | Furosemide |
|---|---|---|
| Relative potency | 1 (reference) | approx. 0.4 (10 mg torasemide ≈ 40 mg furosemide) |
| Bioavailability | 80–90% (stable!) | 10–90% (highly variable!) |
| Duration of action | Up to 12 hours | 4–6 hours |
| Dosing frequency | Once daily | 2–3 times daily |
| Potassium loss | Less | More |
| Magnesium loss | Less | More |
| Ototoxicity | Low | Higher (especially in renal impairment) |
| Elimination | Hepatic (no accumulation risk in renal impairment) | 65% renal (accumulation in renal impairment!) |
| Mortality in HF | Equivalent (TRANSFORM-HF 2022) | Equivalent (TRANSFORM-HF 2022) |
| Cost | Slightly higher | Lower |
Loop diuretics excrete water — but also electrolytes at the same time. This is the most clinically critical side effect of torasemide, requiring regular laboratory monitoring. Potassium and magnesium in particular must be kept in view.
| Electrolyte | Risk under torasemide | Symptoms of deficiency | Consequence |
|---|---|---|---|
| Potassium (hypokalaemia) | Elevated (but lower than furosemide) | Muscle weakness, cramps, cardiac arrhythmias | Monitor potassium! Consider supplementation or adding spironolactone |
| Sodium (hyponatraemia) | Elevated | Confusion, nausea, headaches, seizures | Monitor sodium; watch fluid intake |
| Magnesium (hypomagnesaemia) | Mildly elevated | Muscle cramps, cardiac arrhythmias | Consider magnesium supplementation. See the magnesium article |
This is the most dangerous and simultaneously most common drug interaction in the daily lives of heart failure patients. The term "Triple Whammy" describes what happens when three kidney-damaging mechanisms are active simultaneously.
The mechanism is threefold: the diuretic reduces blood volume and thereby pressure in the kidney. The ACE inhibitor dilates the efferent renal vessel (a desired kidney-protective effect) — but this drops glomerular filtration pressure further. The NSAID now constricts the afferent renal vessel by inhibiting protective prostaglandins. Together, filtration pressure in the kidney can fall so far that acute kidney failure results — sometimes within days.
The insidious aspect: in everyday clinical life, this combination is extremely common. The patient takes torasemide + ramipril for heart failure — and buys ibuprofen over the counter for knee pain. Nobody warns them. Additionally, ibuprofen reduces the diuretic effect of torasemide — the oedema returns. The safe alternative: paracetamol (acetaminophen). Check all combinations with the interaction check.
| Substance / medication | Interaction | Recommendation |
|---|---|---|
| Ibuprofen / diclofenac (NSAIDs) | Diuretic effect reduced + kidney risk | Paracetamol (acetaminophen) instead of NSAIDs! |
| Ramipril/candesartan + NSAIDs | Triple Whammy → acute kidney failure | Contraindicated as a three-way combination! |
| Digoxin | Hypokalaemia → enhanced glycoside toxicity | Close potassium monitoring — mandatory! |
| Lithium | Reduced lithium excretion → toxicity | Monitor lithium levels |
| Aminoglycosides (gentamicin) | Ototoxicity and nephrotoxicity enhanced | Avoid combination or monitor closely |
| Insulin / metformin | Blood glucose may rise (torasemide mildly raises glucose) | Monitor blood glucose; adjust antidiabetic dose if needed |
| Corticosteroids (prednisolone) | Enhanced potassium loss! | Monitor potassium + consider supplementation |
| Alcohol | Enhanced blood pressure lowering, dizziness | Limit intake |
Most side effects of torasemide are either direct consequences of the therapeutic effect (increased urination, blood pressure fall) or consequences of electrolyte loss. Particularly relevant in older patients: the elevated fall risk from dizziness and nocturnal toilet trips.
| Side effect | Frequency | Cause | What to do |
|---|---|---|---|
| Increased urination | Very common | Therapeutic effect! | Take in morning; settles during adjustment phase |
| Dizziness / hypotension | Common | Fall in blood pressure and volume | Rise slowly; maintain adequate fluid intake |
| Muscle cramps | Common | Electrolyte loss (K⁺, Mg²⁺) | Monitor electrolytes; supplement if needed |
| Hyperuricaemia / gout | Common | Competition for renal tubular secretion | Monitor uric acid; note history of gout! |
| Blood glucose rise | Occasional | Metabolic effect | Diabetics: close blood glucose monitoring |
| Headaches / fatigue | Common | Particularly at the start of therapy | Usually improves |
| Nausea / loss of appetite | Occasional | GI effect | Take with breakfast |
| Fall risk (older patients!) | Elevated | Hypotension + urge to urinate | Fall-risk medication (FRIDs). Implement falls prevention measures! |
The timing of torasemide is not a recommendation — it is a clinical necessity. Torasemide has a diuretic effect lasting up to 12 hours. Anyone taking it in the evening will experience the diuretic effect in the middle of the night: frequent toilet trips, disrupted sleep, exhaustion in the morning.
For older patients this has a direct safety consequence: nocturnal trips to the toilet in the dark are one of the most frequent causes of falls. As a diuretic, torasemide belongs to the class of FRIDs (fall-risk-increasing drugs). The fall risk can be substantially reduced by consistent morning intake.
In older patients, torasemide is a FRID — always start low, monitor electrolytes closely, and watch for dehydration. In renal impairment, torasemide has a clear advantage over furosemide: hepatic elimination means no accumulation — usable even in severe renal impairment (up to dialysis) with higher doses (50–200 mg). In hepatic impairment by contrast, caution is needed: hepatic elimination may be impaired, and the risk of electrolyte disturbances and hepatic encephalopathy increases.
| Observation | Frequency | Typical comment |
|---|---|---|
| Triple Whammy not recognised (torasemide + ramipril + ibuprofen) | Very common | "The app warned me I shouldn't take ibuprofen. I didn't know." |
| Evening intake → sleep disturbances | Common | "Since switching to morning intake, my sleep is much better." |
| No electrolyte monitoring | Common | "My potassium was very low — nobody had checked it." |
| Leg cramps from potassium deficiency | Common | "Cramps every night. The app said: check potassium." |
| Switch furosemide → torasemide | Occasional | "My doctor switched me over — now once instead of three times a day." |
| Weight gain as early warning | Occasional | "3 kg in a week — the app warned me to go back to the doctor." |
Torasemide furosemide conversion — how do I convert between them? The equivalent dose is: 10 mg torasemide ≈ 40 mg furosemide (factor of 4). However: this conversion is not exact, because torasemide has a much more stable bioavailability. A patient who was poorly controlled on furosemide may respond differently to torasemide than the formula suggests. When switching: always under medical supervision with weight and electrolyte monitoring.
Torasemide morning — why, and what if I took it in the evening? The diuretic effect lasts up to 12 hours. Anyone taking torasemide in the evening has constant urgency overnight and sleeps poorly. If you accidentally took it in the evening once: no need to panic, but switch to morning from tomorrow. After getting up, with breakfast — so the peak effect is during the day, when you are awake and active.
Torasemide Triple Whammy — what exactly happens to the kidneys? Each of the three medications affects renal blood flow: torasemide reduces blood volume (less perfusion pressure); ramipril dilates the efferent renal vessel (normally protective, but drops pressure further); ibuprofen constricts the afferent renal vessel by inhibiting prostaglandins. Glomerular filtration pressure collapses. The consequence: acute kidney failure with rising creatinine, reduced urine output, and in the worst case dialysis-dependency.
Torasemide potassium — do I always need to take potassium supplements? Not automatically, but potassium levels must be monitored regularly. With normal values, supplementation is not needed. With low values: either potassium supplements or addition of a potassium-sparing diuretic (spironolactone, eplerenone). A potassium-rich diet (bananas, tomatoes, pulses) helps supportively, but does not replace monitoring. Particularly important: with concurrent digoxin therapy, potassium monitoring is mandatory, not optional.
Torasemide heart failure — why such high doses in renal impairment? This is one of torasemide's major advantages: unlike furosemide (65% renal elimination), torasemide is metabolised primarily in the liver. This means it does not accumulate in impaired kidney function. With severe renal impairment, furosemide can build up and become toxic. Torasemide remains effective — but since the kidneys respond less readily to the diuretic, considerably higher doses (50–200 mg) are needed.